Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Maintains a 'Buy' on Google (GOOG); Sizing the Mobile Opportunity
-
Canaccord Genuity Assumes Coverage on REX Energy (REXX) at Buy; Catalysts on the Horizon to Drive H2/11 Outperformance
-
UPDATE - Canaccord Genuity Upgrades SuccessFactors (SFSF) to Buy; Seems Due For At Least A Rebound
-
Canaccord Genuity Upgrades SuccessFactors (SFSF) to Buy
-
Canaccord Genuity on Life Sciences: A Clinical Lab Perspective of C. Difficile Testing
-
Canaccord Genuity Reiterates a 'Buy' on Jamba (JMBA); Nearing the Next Phase, Should Be Evident in P&L
-
Canaccord Genuity reiterates a 'Buy' on Oracle (ORCL); Solid Print Caps Off an Excellent Year, Outlook Bodes Well
-
Canaccord Genuity Reiterates a 'Buy' on Anaren (ANEN); Well Positioned for Strong Growth and Expanding Margins
-
Canaccord Genuity Remains Buyers of Heartware Intl (HTWR) at Current Levels
-
Canaccord Genuity Reiterates a 'Buy' on Raptor Pharmaceuticals (RPTP); Management Update: RP103 Phase 3 Data on Track, Q1/12 NDA
-
Canaccord Genuity Assumes Coverage on Triangle Petroleum (TPLM) at Buy; Bakken Province Secured; Focused on First Operated Well
-
Canaccord Genuity Reiterates a 'Buy' on Imris Inc. (IMRS); Take-Aways From Company Visit
-
Canaccord Genuity maintains a 'Buy' on Apogee Enterprises (APOG); More Signs of Recovery
-
Canaccord Genuity Reiterates a 'Buy' on Oracle (ORCL); Solid May Quarter Likely, but We'd Bet on Conservative H1 Guidance
-
Canaccord Genuity maintains a 'Buy' on Weatherford International (WFT); Mid-Quarter Update
-
Canaccord Genuity reiterates a 'Buy' on EnteroMedics (ETRM); Takeaways From Annual ASMBS Meeting
-
Canaccord Genuity Reiterates a 'Hold' on AspenBio Pharma (APPY); Clinical Timelines Updated
-
Canaccord Genuity Maintains a 'Buy' on Casella Waste Systems (CWST); Adjusting Estimates
-
Canaccord Genuity Maintains a 'Buy' on Nabors (NBR); Q2 Preannouncement, but Keeping Eye on 2012 Prize
-
Canaccord Genuity Assumes Coverage on SM Energy (SM) at Buy; Unfettered Eagle Ford Should Drive Outperformance
-
Canaccord Genuity Reiterates a 'Buy' on Badger Meter (BMI); Mid-Quarter Checks Holding Up
-
Canaccord Genuity Maintains a 'Buy' on Brocade (BRCD); Fundamentals Solid, M&A Remains a Call Option
-
Canaccord Genuity Assumes Coverage on Cimarex Energy (XEC) at Buy; Upside in Horizontal Delaware Basin Development
-
Canaccord Genuity Reiterates a 'Buy' on Aegerion Pharmaceuticals (AEGR); Positive Pre-NDA Meeting Bodes Well for Lomitapide's Chances
-
Canaccord Genuity Maintains a 'Hold' on AOL, Inc. (AOL); Analyst Day Focus on Growth
-
Canaccord Genuity Maintains a 'Hold' on Research In Motion (RIMM); Further Product Delays: F2012 Guidance Lowered Again
-
Canaccord Genuity Maintains a 'Hold' on Transocean (RIG); Two More Midwater Contracts
-
Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Current Valuation Overrepresents Ultimate Market Opportunity
-
Canaccord Genuity Maintains a 'Hold' on Rubicon Technology (RBCN); Reaffirms Guidance, Clarifies Tax Assumptions
-
Canaccord Genuity Reiterates a 'Buy' on MKS Instruments (MKSI); Lowers Q2 Outlook on Analyst Day; Buy on Short Spending Dip
-
Canaccord Genuity Maintains a 'Buy' on Parametric Technology (PMTC); Investor Update
-
Canaccord Genuity Reiterates a 'Buy' on Raptor Pharmaceuticals (RPTP); Cystinosis Expert Call: Unmet Need, Strong Case for Success
-
Canaccord Genuity Maintains a 'Buy' on FuelCell Energy (FCEL); Management Transition Continues
-
Canaccord Genuity Maintains a 'Hold' on Diamond Offshore (DO); Minor Changes After Fleet Status Update
-
Unusual 11 Mid-Day Movers 06/14: (DANG) (NQ) (LMLP) Higher; (KV-A) (COOL) (PCRX) Lower
-
Notable Analyst Rating Changes 06/14: (DMD) (DRYS) (WFR) Upgraded; (SPWRA) (AAP) (ANGO) Downgraded
-
Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Final Shoe May Have Dropped
-
UPDATE - Canaccord Genuity Initiates Coverage on MAKO Surgical (MAKO) with a Hold; Knee is Driving Growth; Hip Too Early to Call
-
Canaccord Genuity Reiterates a 'Buy' on Green Mountain Coffee Roasters (GMCR); A Dunkin' Donuts K-cup with Your Lobster Roll
-
Canaccord Genuity Reiterates a 'Buy' on Spreadtrum Communications (SPRD); Broadens Portfolio Via MobilePeak Acquisition
-
Canaccord Genuity Reiterates a 'Buy' on Anaren (ANEN); Wireless Trends Strong, Tempering Estimates on Space & Defense
-
Canaccord Genuity Starts NetQin Mobile (NQ) at Buy; Fast Growing Smartphone Market
-
Canaccord Genuity Upgrades Petroleum Development (PETD) to Buy; Sell-off, Assets Present Opportunity
-
Canaccord Genuity Starts MAKO Surgical (MAKO) at Hold
-
Notable 52-Week Highs and Lows of the Day 06/13: (ORS) (INSM) (FRX) High; (NOK) (RIMM) (BZH) Low
-
Notable ETF Movers of the Day 06/13: (FXI) (FXE) (TAN) Higher; (UNG) (SLV) (EWT) Lower
-
Canaccord Genuity May, Mid-June Checks - iPhone and Android Market Share Gains Continue
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Management Dinner Takeaways
-
Canaccord Genuity Maintains a 'Buy' on EnerNOC (ENOC); Painting the Three-Year Picture
-
Canaccord Genuity Maintains a 'Hold' on United Natural Foods (UNFI); Sale of Noncore Assets Add to Earnings and Growth Rate
